Clinical trial
Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan After Oral Administration Using 240 ml Non-caloric Water, a Carbohydrate Enriched Drink and Grapefruit Juice in Correlation to the Intestinal Availability of Water as Quantified by MRI-based Volumetry in 9 Healthy Male and Female Subjects
NCT03012763 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan After Oral Administration Using 240 ml Non-caloric Water, a Carbohydrate Enriched Drink and Grapefruit Juice in Correlation to the Intestinal Availability of Water as Quantified by MRI-based Volumetry in 9 Healthy Male and Female Subjects
- Lead sponsor
- University Medicine Greifswald
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- Not reported
- Enrollment
- 9 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
administration, oral, magnetic resonance imaging, pharmacokinetics